Ocugen (OCGN) Competitor Comparison
We are evaluating the key criteria listed to compare Ocugen (OCGN) against its competitors in the Biotechnology industry.
Market Capitalization
213 / 368Gross Profits
198 / 278Total Revenue
0 / 300EBITDA
177 / 337Free Cashflow
219 / 352Quick Ratio
190 / 357Earnings per Share
50 / 359Dividend yield
0 / 6Total Cash
255 / 358Performance 3 years
275 / 368Performance 5 years
310 / 368Performance 10 years
351 / 368Linearity 3 years
268 / 368Linearity 5 years
303 / 368Linearity 10 years
310 / 368Total Rank
212 / 368Dividend Rank
222 / 368Valuation Rank
363 / 368Piotroski Rank
130 / 368Muliplier Rank
63 / 368Dividend Rank - OCGN ranking 222 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.